Abstinence symptoms following oral THC administration to humans

Psychopharmacology

Volumn 141, Issue 4, 1999, Pages 385-394

  Haney, Margaret ^a   Ward, Amie S ^a   Comer, Sandra D ^a   Foltin, Richard W ^a   Fischman, Marian W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Dependence Tolerance; Food intake; Human; Marijuana; Performance; Subjective effect; THC; Withdrawal

Indexed keywords

CANNABIS; PLACEBO; TETRAHYDROCANNABINOL;

ADULT; ANXIETY; ARTICLE; DEPRESSION; DRUG DEPENDENCE; DRUG TOLERANCE; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; IRRITABILITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRE; RECREATION; SLEEP; SOCIAL BEHAVIOR; WITHDRAWAL SYNDROME;

ADMINISTRATION, ORAL; ADULT; APPETITE; APPETITE STIMULANTS; CANNABIS; DRUG TOLERANCE; EATING; FEMALE; HUMANS; MALE; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; SOCIAL BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL;

EID: 0032932488     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050848     Document Type: Article

References (37)

1. Aceto MD, Scales SM, Lowe JA, Martin BR (1995) Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Eur J Pharmacol 282:R1-R2
2. Anthony JC, Warner LA, Kessler RC (1994) Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the national comorbidity survey. Exp Clin Psychopharmacol 2:244-268
3. Babor TF, Mendelson JH, Greenberg I, Kuehnle JC (1975) Marijuana consumption and tolerance to physiological and subjective effects. Arch Gen Psychiatry 32:1548-1552
4. Beardsley PM, Balster RL, Harris LS (1986) Dependence on tetrahydrocannabinol in rhesus monkeys. J Pharmacol Exp Ther 239:311-319
5. Brower KJ, Maddahian E, Low FC, Beresford TP (1988) A comparison of self-reported symptoms and DSM-III-R criteria for cocaine withdrawal. Am J Drug Alcohol Abuse 14:347-356
6. Budney AJ, Kandel DB, Cherek DR, Martin BR, Stephens RS, Roffman R (1997) College on Problems of Drug Dependence Meeting, Puerto Rico (June, 1996): Marijuana use and dependence. Drug Alcohol Depend 45:1-24
7. Budney AJ, Radonovich KJ, Higgins ST, Wong C (1998) Adults seeking treatment for marijuana dependence: a comparison to cociane-dependent treatment seekers. Exp Clin Psychopharmacol (in press)
8. Cohen MJ, Rickles WH Jr (1974) Performance on a verbal learning task by subjects of heavy past marijuana usage. Psychopharmacologia 37:323-330
9. Foltin RW, Fischman MW (1988) Effects of smoked marijuana on human social behavior in small groups. Pharmacol Biochem Behav 30:539-541
10. Foltin RW, Haney M, Comer SD, Fischman MW (1996) Effect of fluoxetine on food intake of humans living in a residential laboratory. Appetite 27:165-181
11. Frank B, Galea J (1995) Epidemiologic trends in drug abuse v. II. NIDA US Dept Health and Human Services, NIH
12. Halbreich U, Endicott J, Schacht S (1982a) Premenstrual syndromes: a new instrument for their assessment. J Psychiatr Treat Eval 4:161-164
13. Halbreich U, Endicott J, Schacht S, Nee J (1982b) The diversity of pre-menstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr 65:46-65
14. Haney M, Comer SD, Ward AS, Foltin RW, Fischman MW (1997) Factors influencing marijuana self-administration by humans. Behav Pharmacol 8:101-112
15. Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38: 1-20
16. 9-tetrahydrocannabinol reflect the degree of intoxication? J Clin Pharmacol 21:171S-177S
17. Johnston LD, O'Malley PM, Bachman JG (1995) National survey results on drug use from the monitoring the future study, 1975-1994, vol 1. US Department of Health and Human Services, Washington, D.C.
18. Johnston LD, O'Malley PM, Bachman JG (1997) Monitoring the future study: 1975-1995. II: US Dept Health and Human Services, NIH
19. Jones RT, Benowitz N, Bachman J (1976) Clinical studies of cannabis tolerance and dependence. Ann NY Acad Sci 282: 221-239
20. Jones RT, Benowitz NL, Herning RI (1981) Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21: 143S-152S
21. 9-tetrahydrocannabinol on repeated acquisition and performance of response sequences and on self-reports in humans. Behav Pharmacol 5:71-78
22. Kaymakcalan S (1973) Tolerance to and dependence on cannabis. Bull Narcot 25:39-47
23. Kelly TH, Foltin RW, Emurian CS, Fischman MW (1993a) Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J Anal Toxicol 17:264-272
24. Kelly TH, Foltin RW, Emurian CS, Fischman MW (1993b) Effects of smoked marijuana on heart rate, drug ratings and task performance by humans. Behav Pharmacol 4:167-178
25. Koob GF, Caine SB, Parsons L, Markou A, Weiss F (1997) Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav 57:513-521
26. McLaren DS (1976) Nutrition and its disorders, 2nd edn. Churchill Livingstone, New York
27. 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use. Psychopharmacology 83: 351-356
28. Mendelson JH, Kuehnle JC, Greenberg I, Mello NK(1976) Operant acquisition of marijuana in man. J Pharmacol Exp Ther 198: 42-53
29. Meyer RE, Pillard RC, Shapiro LM, Mirin SM (1971) Administration of marijuana to heavy and casual marijuana users. Am J Psychiatry 128:198-204
30. Nowlan R, Cohen S (1977) Tolerance to marijuana: heart rate and subjective "high." Clin Pharmacol Ther 22:550-556
31. Rickles WH Jr Cohen MJ, Whitaker CA, McIntyre KE (1973) Marijuana induced state-dependent verbal learning. Psychopharmacologia 30:349-354
32. Rodriguez de Fonseca F, Carrera MRA, Navarro M, Koob GF, Weiss F (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276: 2050-2053
33. Stephens RS, Roffman RA, Simpson EE (1993) Adult marijuana users seeking treatment. J Consult Clin Psychol 61:1100-1104
34. Stephens RS, Roffman RA, Simpson EE (1994) Treating adult marijuana dependence: a test of the relapse prevention model. J Consult Clin Psychol 62:92-99
35. 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur J Pharmacol 280:R13-R15
36. Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M (1983) Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 34: 352-363
37. Wiesbeck GA, Shuckit MA, Kalmijn JA, Tipp JE, Bucholz KK, Smith TL (1996) An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 91: 1469-1478